Bitwise MARA Option Income Strategy ETF IMRA
Set alert
14.59 USD +0.07 +0.48%
As of Jul 31, 3:59 PM ET
14.48 Day range 14.59
11.99 52-week range 42.32
- YTD
- +0.83%
- 1 year
- -70.26%
- Open
- 14.48
- Prev close
- 14.52
- Mkt cap
- 165.80M
- Vol
- 2.98K
- Avg vol
- 3.39K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.48
- High
- 14.59
- Forward P/E
- -11.92
- Beta
- 1.08
- Short ratio
- 2.00
- Inst. own
- 81.32%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 10, 2023
- 50-d avg
- 4.55
- 200-d avg
- 2.85
- 1y target
- 1.40
Key statistics
- Market cap
- 165.80M
- Enterprise value
- 77.60M
- Trailing P/E
- 105.33
- Forward P/E
- -11.92
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 1.84
- EPS (TTM)
- 0.06
- Beta
- 1.08
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -22.73M
- Total cash
- 88.20M
- Total debt
- 0
- Return on equity
- 1.69%
- Shares outstanding
- 26.23M
- Short % of float
- 2.46%
- 50-day average
- 4.55
- 200-day average
- 2.85
Analyst view
Consensus: hold
Hold
Price target (mean) 1.40
Next earnings
Feb 10, 2023
Expected Feb 10, 2023. Consensus EPS estimate -0.20.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 10, 2023 | Dec 1, 2022 | 0.00 | — | — | — |
| Oct 25, 2022 | Sep 1, 2022 | 0.00 | — | — | — |
| Aug 3, 2022 | Jun 1, 2022 | -0.56 | — | — | — |
| May 6, 2022 | Mar 1, 2022 | -0.57 | — | — | — |
| Mar 15, 2022 | Dec 1, 2021 | -0.79 | — | — | — |
| Nov 9, 2021 | Sep 1, 2021 | -0.91 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 6, 2022 | SVB Leerink | down | Outperform | Market Perform |
| Mar 16, 2022 | SVB Leerink | main | — | Outperform |
| Jan 6, 2022 | Morgan Stanley | main | — | Equal-Weight |
| Nov 30, 2021 | HC Wainwright & Co. | init | — | Buy |
| Aug 11, 2021 | Morgan Stanley | down | Overweight | Equal-Weight |
| Apr 19, 2021 | Morgan Stanley | main | — | Overweight |
About Bitwise MARA Option Income Strategy ETF
IMARA Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapeutics to treat patients suffering from serious diseases. The company was incorporated in 2016 and is based in Brookline, Massachusetts.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- imaratx.com
News
- Bitwise Announces Updates to ETF Lineup
- Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH
- Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Short Interest Up 3,395.1% in April
- Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH
- Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH
- Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH
- Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH
- Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH
- Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH
- Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, and IGME
Your note
Sign in to keep a note on IMRA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ATTIE KENNETH | Officer | Stock Award(Grant) | Jan 27, 2022 | 34,100 |
| BALLAL RAHUL D. | Chief Executive Officer | Sale | Feb 21, 2023 | 87,835 |
| BONITA DAVID P | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Jul 15, 2021 | 0 |
| COMMODORE CAPITAL LP | Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 21, 2023 | 0 |
| GRAY MICHAEL P | Chief Operating Officer | Sale | Feb 21, 2023 | 27,610 |
| LEONARD BRADEN MICHAEL | Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 3, 2023 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Orbimed Advisors LLC. | 16.72% | 4,386,568 | 27.72M | Dec 30, 2022 |
| RA Capital Management, L.P. | 12.39% | 3,250,724 | 20.54M | Dec 30, 2022 |
| Bml Capital Management, LLC | 11.50% | 3,017,774 | 19.07M | Dec 30, 2022 |
| Commodore Capital, LP | 9.51% | 2,494,794 | 15.77M | Dec 30, 2022 |
| Janus Henderson Group PLC | 3.54% | 928,706 | 5.87M | Dec 30, 2022 |
| Woodline Partners LP | 3.30% | 866,405 | 5.48M | Dec 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 0.87% | 227,220 | 1.44M | Sep 29, 2022 |
| Fidelity Extended Market Index Fund | 0.28% | 72,317 | 457.04K | Nov 29, 2022 |
| Fidelity Advisor Biotechnology Fund | 0.26% | 66,947 | 423.11K | Dec 30, 2022 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.25% | 66,800 | 422.18K | Sep 29, 2022 |
| Vanguard Extended Market Index Fund | 0.25% | 65,610 | 414.65K | Sep 29, 2022 |
| Bridgeway Funds Inc-Ultra Small Company Fund | 0.21% | 54,700 | 345.70K | Sep 29, 2022 |